Transgenic mouse models to study human mineralocorticoid receptor function in vivo

Kidney International

Volumn 57, Issue 4, 2000, Pages 1299-1306

  Le Menuet, Damien ^a   Zennaro, Maria Christina ^a   Viengchareun, Say ^a   Lombès, Marc ^a  

^a INSERM   (France)

Author keywords

Aldosterone; Epithelia; Gene promotion; Oncogenesis; Transcription factor

Indexed keywords

ALDOSTERONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; VIRUS LARGE T ANTIGEN;

ANIMAL MODEL; BRAIN CANCER; CELL IMMORTALIZATION; CONFERENCE PAPER; EXON; GENE FUNCTION; GENE OVEREXPRESSION; HORMONE ACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

EID: 0034028942     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00966.x     Document Type: Conference Paper

References (50)

1. 1. ARRIZA JL, WEINBERGER C, CERELLI G, GLASER TM, HANDELIN BL, HOUSMAN DE, EVANS RM: Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 237:268-275, 1987
2. 2. FUNDER JW, FELDMAN D, EDELMAN IS: Specific aldosterone hinding in rat kidney and parotid. J Steroid Biochem 3:209-218, 1972
3. 3. FARMAN N, OBLIN ME, LOMBES M, DELAHAYE F, WESTPHAL HM, BONVALET JP, GASC JM: Immunolocalization of gluco-and mineral-ocorticoid receptors in rabbit kidney. Am J Physiol 260:C226-C233, 1991
4. 4. PRESSLEY LA, FUNDER JW: Glucocorticoid and mineralocorticoid receptors in gut mucosa. Endocrinology 97:588-596, 1975
5. 5. RAFESTIN-OBLIN ME, LOMBÈS M, MICHEL JB, MICHAUD A, CLAIRE M: Mineralocorticoid receptors in the epithelial cells of human colon and ileum. J Steroid Biochem 20:311-315, 1984
6. 6. SUZUKI T, SASANO H, SUZUKI S, HIRASAWA G, TAKEYAMA J, MURAMATSU Y, DATE F, NAGURA H, KROZOWSKI ZS: 11 Beta-hydroxysteroid dehydrogenase type 2 in human lung: Possible regulator of mineralocorticoid action. J Clin Endocrinol Metab 83:4022-4025, 1998
7. 7. KENOUCH S, LOMBÈS M, DELAHAYE F, EUGÈNE E, BONVALET JP, FARMAN N: Human skin as target for aldosterone: Coexpression of mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 79:1334-1341, 1994
8. 8. ALBISTON AL, OBEYESEKERE WR, SMITH RE, KROZOWSKI ZS: Cloning and tissue distribution of the human 11beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105:R11-R17, 1994
9. 9. FUNDER JW, PEARCE PT, SMITH R, SMITH AI: Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585, 1988
10. 10. EDWARDS CR, STEWART PM, BURT D, BRETT L, MCINTYRE MA, SUTANTO WS, DE KLOET ER, MONDER C: Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2:986-989, 1988
11. 11. WHITE PC, MUNE T, AGARWAE AK: 11 Beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18:135-156, 1997
12. 12. FARMAN N: Molecular and cellular determinants of mineralocorticoid selectivity. Curr Opin Nephrol Hypertens 8:45-51, 1999
13. 13. COUETTE B, FAGART J, JALAGUIER S, LOMBÈS M, SOUQUE A, RAFESTIN-OBLIN ME: Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure. Biochem J 315:421-427, 1996
14. 14. FAGART J, WURTZ JM, SOUQUE A, HELLAL-LEVY C, MORAS D, RAFESTIN-OBLIN ME: Antagonism in the human mineralocorticoid receptor. EMBO J 17:3317-3325, 1998
15. 15. LOMBÈS M, KENOUCH S, SOUQUE A, FARMAN N, RAFESTIN-OBLIN M-E: The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840, 1994
16. 16. COUETTE B, JALAGUIER S, HELLAL-LEVY C, LUPO B, FAGART J, AUZOU G, RAFESTIN-OBLIN ME: Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor. Mol Endocrinol 12:855-863, 1998
17. 17. PEARCE P, FUNDER JW: High affinity aldosterone binding sites (type 1 receptors) in rat heart. Clin Exp Pharmacol Physiol 14:859-866, 1987
18. 18. LOMBÈS M, ALFAIDY N, EUGENE E, LESSANA A, FARMAN N, BONVALET J-P: Prerequisite for cardiac aldosterone action: Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 92:175-182, 1995
19. 19. DE KLOET R, WALLACH G, MCEWEN BS: Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 96:598-609, 1975
20. 20. REUL JM, DE KLOET ER: Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 117:2505-2511, 1985
21. 21. DE KLOET ER, VREUGDENHIL E, OITZL MS, JOELS M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301, 1998
22. 22. MEYER WJI, NICHOLS N: Mineralocorticoid binding in cultured smooth muscle cells and fibroblast from rat aorta. J Steroid Biochem 14:1157-1168, 1981
23. 23. LOMBÈS M, OBLIN M-E, GASC JM, BAULIEU EE, FARMAN N, BONVALET J-P: Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 71:503-510, 1992
24. 24. ARMANINI D, STRASSER T, WEBER PC: Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol 248:E288-E290, 1985
25. 25. LOMBÈS M, BINART N, OBLIN M-E, JOULIN V, BAULIEU EE: Characterization of the interaction of the human mineralocorticosteroid receptor with hormone responsive elements. Biochem J 292:577-583, 1993
26. 26. MCKENNA NJ, LANZ RB, O'MALLEY BW: Nuclear receptor coregulators: Cellular and molecular biology. Endocr Rev 20:321-344, 1999
27. 27. ZENNARO M-C, KEIGHTLEY MC, KOTELEVTSEV Y, CONWAY G, SOUBRIER F, FULLER PJ: Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J Biol Chem 270:21016-21020, 1995
28. 28. ZENNARO M-C, LE MENUET D, LOMBÈS M: Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: Evidence for differential hormonal regulation of two alternative promoters via non-classical mechanisms. Mol Endocrinol 10:1549-1560, 1996
29. 29. KWAK SP, PATEL PD, THOMPSON RC, AKIL H, WATSON SJ: 5′-heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: Differential expression and regulation of splice variants within rat hippocampus. Endocrinology 133:2344-2350, 1993
30. 30. ZENNARO MC, LOMBÈS M: Mineralocorticoid receptor isoforms. Curr Opin Endocrinol Diabetes 5:183-188, 1998
31. 31. TRAPP T, RUPPRECHT R, CASTRÈN M, REUL JMHM, HOLSBOER F: Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS. Neuron 13:1457-1462, 1994
32. 32. CLAIRE M, OBLIN ME, STEINER JL, NAKANE M, MISUMI J, MICHAUD A, CORVOL P: Effect of adrenalectomy and aldosterone on the modulation of aldosterone receptors in rat kidney. J Biol Chem 256:142-147, 1980
33. 33. REUL JMHM, PEARCE PT, FUNDER JW, KROZOWSKI ZS: Type I and type II corticosteroid receptor gene expression in the rat: Effect of adrenalectomy and dexamethasone administration. Mol Endocrinol 3:1674-1680, 1989
34. 34. STEPHENSON G, FUNDER J: Hippocampal and renal type I receptors are differentially regulated. Am J Physiol 252:E525-E529, 1987
35. 35. ESCOUBET B, COUREAU C, BLOT-CHABAUD M, BONVALET JP, FARMAN N: Corticosteroid receptor mRNA expression is unaffected by corticosteroids in rat kidney, heart, and colon. Am J Physiol 270:C1343-C1353, 1996
36. 36. MEYER AS, SCHMIDT TJ: In contrast to glucocorticoid receptors, mineralocorticoid receptors are not autoregulated in rat distal colon epithelia. Endocrinology 134:1163-1172, 1994
37. 37. STRAHLE U, SCHMIDT A, KELSEY G, STEWART AF, COLE TJ, SCHMID W, SCHUTZ G: At least three promoters direct expression of the mouse glucocorticoid receptor gene. Proc Natl Acad Sci USA 89:6731-6735, 1992
38. 38. ZENNARO M-C, FARMAN N, BONVALET J-P, LOMBÈS M: Tissue-specific expression of α and β mRNA isoforms of the human mineralocorticoid receptor in normal and pathological states. J Clin Endocrinol Metab 82:1345-1352, 1997
39. 39. GORDON RD: Heterogeneous hypertension. Nat Genet 11:6-9, 1995
40. 40. SHIMKETS RA, WARNOCK DG, BOSITIS CM, NELSON-WILLIAMS C, HANSSON JH, SCHAMBELAN M, GILL JR JR, ULICK S, MILORA RV, FINDLING JW, CANESSA CM, ROSSIER BL, LIFTON RP: Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407-414, 1994
41. 41. HANSSON JH, NELSON-WILLIAMS C, SUZUKI H, SCHILD L, SHIMKETS R, LU Y, CANESSA C, IWASAKI T, ROSSIER B, LIFTON RP: Hypertension caused by a truncated epithelial sodium channel gamma subunit: Genetic heterogeneity of Liddle syndrome. Nat Genet 11:76-82, 1995
42. 42. ZENNARO M-C: Syndromes of glucocorticoid and mineralocorticoid resistance. Eur J Endocrinol 139:127-138, 1998
43. 43. ZENNARO M-C, LE MENUET D, VIENGCHAREUN S, WALKER F, RICQUIER D, LOMBÈS M: Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J Clin Invest 101:1254-1260, 1998
44. 44. RONDINONE CM, RODBARD D, BAKER ME: Aldosterone stimulates differentiation of mouse 3T3-1.1 cells into adipocytes. Endocrinology 132:2421-2426, 1993
45. 45. SPICER AP, PARRY G, PATION S, GENDLER SJ: Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism. J Biol Chem 266:15099-15109, 1991
46. 46. JARRARD JA, LINNOILA RI, LEE H, STEINBERG SM, WHSCHI H, SZABO E: MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res 58:5582-5589, 1998
47. 47. ECKERT WJ: Epidermal keratinocytes-genes and their regulation. Death Differ 3:373-383, 1996
48. + metabolism. Proc Natl Acad Sci USA 95:9424-9429, 1998
49. 49. BLEICH M, WARTH R, SCHMIDT-HIEBER M, SCHULZ-BALDES A, HASSELBLATT P, FISCH D, BERGER S, KUNZELMANN K, KRIZ W, SCHUTZ G, GREGER R: Rescue of the mineralocorticoid receptor knockout mouse. Pflügers Arch 438:245-254, 1999
50. 50. GELLER DS, RODRIGUEZ-SORIANO J, VALLO BOADO A, SCHIFTER S, BAYER M, CHANG, SS, LIFTON RP: Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 19:279-281, 1998